Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines - PubMed (original) (raw)
. 2001 Aug 16;20(36):5025-32.
doi: 10.1038/sj.onc.1204611.
Affiliations
- PMID: 11526487
- DOI: 10.1038/sj.onc.1204611
Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines
J Gayet et al. Oncogene. 2001.
Abstract
A number of genetic alterations have been described in colorectal cancers. They include allelic losses on specific chromosomal arms, mutations of oncogenes, tumor suppressor genes and mismatch repair genes, microsatellite instability in coding repeat sequences of target genes and methylation defects in gene promoters. Since these alterations have been reported by different groups on different tumors and cell lines, the complete repertoire of genetic alterations for any given tumor sample remains unknown. In the present study, we analysed a series of 22 colorectal cancer cell lines for 31 different genetic alterations. We found significant correlations between mutational profiles in these colorectal cell lines associated with differences in mismatch repair status. This panel of colon cancer cell lines is representative of the genetic heterogeneity occurring in sporadic colorectal carcinoma. Our results may prove to be very useful for understanding the different biological pathways involved in the development of colon cancer, and for groups studying cellular biology and pharmacology on the same cell lines.
Similar articles
- Frequent alterations of the beta-catenin and TCF-4 genes, but not of the APC gene, in colon cancers with high-frequency microsatellite instability.
Fukushima H, Yamamoto H, Itoh F, Horiuchi S, Min Y, Iku S, Imai K. Fukushima H, et al. J Exp Clin Cancer Res. 2001 Dec;20(4):553-9. J Exp Clin Cancer Res. 2001. PMID: 11876551 - Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers.
Vécsey-Semjén B, Becker KF, Sinski A, Blennow E, Vietor I, Zatloukal K, Beug H, Wagner E, Huber LA. Vécsey-Semjén B, et al. Oncogene. 2002 Jul 11;21(30):4646-62. doi: 10.1038/sj.onc.1205577. Oncogene. 2002. PMID: 12096341 - Different genetic features associated with colon and rectal carcinogenesis.
Frattini M, Balestra D, Suardi S, Oggionni M, Alberici P, Radice P, Costa A, Daidone MG, Leo E, Pilotti S, Bertario L, Pierotti MA. Frattini M, et al. Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4015-21. doi: 10.1158/1078-0432.CCR-04-0031. Clin Cancer Res. 2004. PMID: 15217933 - [Genetic alterations and molecular mechanisms underlying colorectal tumorigenesis].
Ronchetto F. Ronchetto F. Minerva Med. 1998 May;89(5):163-8. Minerva Med. 1998. PMID: 9676181 Review. Italian.
Cited by
- Exploiting the Therapeutic Interaction of WNT Pathway Activation and Asparaginase for Colorectal Cancer Therapy.
Hinze L, Labrosse R, Degar J, Han T, Schatoff EM, Schreek S, Karim S, McGuckin C, Sacher JR, Wagner F, Stanulla M, Yuan C, Sicinska E, Giannakis M, Ng K, Dow LE, Gutierrez A. Hinze L, et al. Cancer Discov. 2020 Nov;10(11):1690-1705. doi: 10.1158/2159-8290.CD-19-1472. Epub 2020 Jul 23. Cancer Discov. 2020. PMID: 32703769 Free PMC article. - c-Cbl mediates the degradation of tumorigenic nuclear β-catenin contributing to the heterogeneity in Wnt activity in colorectal tumors.
Shashar M, Siwak J, Tapan U, Lee SY, Meyer RD, Parrack P, Tan J, Khatami F, Francis J, Zhao Q, Hartshorn K, Kolachalama VB, Rahimi N, Chitalia V. Shashar M, et al. Oncotarget. 2016 Nov 1;7(44):71136-71150. doi: 10.18632/oncotarget.12107. Oncotarget. 2016. PMID: 27661103 Free PMC article. - Abnormal Wnt and PI3Kinase signaling in the malformed intestine of lama5 deficient mice.
Ritié L, Spenlé C, Lacroute J, Bolcato-Bellemin AL, Lefebvre O, Bole-Feysot C, Jost B, Klein A, Arnold C, Kedinger M, Bagnard D, Orend G, Simon-Assmann P. Ritié L, et al. PLoS One. 2012;7(5):e37710. doi: 10.1371/journal.pone.0037710. Epub 2012 May 30. PLoS One. 2012. PMID: 22666383 Free PMC article. - The Wnt signaling pathway and its role in tumor development.
Lustig B, Behrens J. Lustig B, et al. J Cancer Res Clin Oncol. 2003 Apr;129(4):199-221. doi: 10.1007/s00432-003-0431-0. Epub 2003 Apr 18. J Cancer Res Clin Oncol. 2003. PMID: 12707770 Review. - Expression of NHERF1 in colonic tumors induced by 1,2-dimethylhydrazine in rats is independent of plasma ovarian steroids.
Troncoso M, Cuello Carrión FD, Guiñazu E, Fanelli MA, Montt-Guevara M, Cabrini RL, Carón RW, Kreimann EL. Troncoso M, et al. Horm Cancer. 2011 Aug;2(4):214-23. doi: 10.1007/s12672-011-0075-5. Horm Cancer. 2011. PMID: 21761111 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous